JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us
Esta página ha sido traducida por una máquina. Otras páginas pueden seguir apareciendo en inglés. View in English

Contribuciones significativas de los genotipos de la interleucina-13 a la gravedad del asma

  • 0Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan, R.O.C.
In Vivo +

|

28 de agosto de 2025

|

28 de agosto de 2025

Ver abstracta en PubMed

Resumen

Este resumen es generado por máquina.

Las variantes genéticas de la interleucina-13 (IL-13) rs1800925 y rs20541 no están relacionadas con el riesgo general de asma en Taiwán. Sin embargo, la IL- 13 rs1800925 se asocia con un mayor riesgo de asma en adultos más jóvenes y síntomas graves de asma.

Área De La Ciencia

  • La genética
  • Inmunología
  • Medicina de las vías respiratorias

Sus Antecedentes

  • El asma es una enfermedad inflamatoria compleja de las vías respiratorias con influencias genéticas y ambientales.
  • Los polimorfismos genéticos de la interleucina-13 (IL-13), específicamente rs1800925 y rs20541, están implicados en el desarrollo del asma.

Objetivo Del Estudio

  • Investigar la asociación de los polimorfismos de IL-13 (rs1800925 y rs20541) con la susceptibilidad y la gravedad del asma en una población taiwanesa.

Principales Métodos

  • Genotipado de 198 pacientes adultos con asma y 453 controles para la IL-13 rs1800925 y rs20541 utilizando ensayos basados en PCR.
  • Se utilizaron modelos de regresión logística para analizar las asociaciones con el riesgo de enfermedad, la edad, el sexo y la gravedad del asma.

Principales Resultados

  • No se encontró una asociación significativa entre el riesgo de asma y la IL-13 rs1800925 o rs20541 en la población general.
  • El genotipo rs1800925 TT mostró una tendencia hacia un mayor riesgo de asma en individuos de 25 a 40 años.
  • Significativamente, los genotipos rs1800925 CT y TT se asociaron con síntomas de asma más severos, y los portadores de CT+TT tenían mayores probabilidades de asma grave.

Conclusiones

  • La IL-13 rs1800925 y rs20541 no están significativamente relacionadas con la susceptibilidad general al asma en adultos taiwaneses.
  • El polimorfismo de IL-13 rs1800925 puede ser un potencial biomarcador genético para predecir la gravedad del asma, particularmente en adultos más jóvenes y en aquellos con síntomas graves.

Palabras clave:

Videos de Conceptos Relacionados

Asthma-II: Pathophysiology and Classification 01:26

2.8K

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:

Initiation of Airway Inflammation:

...

Asthma-I: Introduction 01:29

2.8K

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...

Asthma: Pathogenesis and Management 01:20

576

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.

Asthma-III: Symptoms and Complications 01:24

2.6K

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma

Intermittent Asthma:

Symptoms occur fewer than twice a week.
Night-time awakenings due to asthma occur fewer than twice a...

Asthma-IV: Diagnostic and Management 01:30

2.6K

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:

Detailed Medical History: This includes asking about symptoms such as wheezing, coughing, chest tightness, and breathlessness. Information about triggers like exercise, allergens, or cold air is crucial.
Physical...

Antiasthma Drugs: Leukotriene Modifiers 01:19

461

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:

5-Lipoxygenase Inhibitors: Some drugs in this class, like zileuton (Zyflo), inhibit an enzyme called 5-lipoxygenase. This enzyme is crucial in synthesizing...